Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aramchol in HIV-associated NAFLD
NCT02684591Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Jan 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aramchol in non-alcoholic fatty liver disease (NAFLD), lipodystrophy, sponsored by University of California, San Diego. Started Jan 2016; status: completed.
02
Drugs
aramchol
03
Conditions
non-alcoholic fatty liver disease (NAFLD)lipodystrophy
Beyond the preview
Go deeper on NCT02684591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684591.